The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

被引:878
|
作者
Hanifin, JM
Thurston, M
Omoto, M
Cherill, R
Tofte, SJ
Graeber, M
机构
[1] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA
[2] Novartis Pharmaceut, Summit, NJ 07901 USA
[3] Shiga Univ Med Sci, Shiga, Japan
关键词
atopic dermatitis; eczema; psoriasis;
D O I
10.1034/j.1600-0625.2001.100102.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective - To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. Design: Training of evaluators, application, and assessment over 2 consecutive days. Setting - An academic center. Patients - Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients rs years) and cohort 2 (10 patients <8 years). Interventions - None. Main outcome measure - The EASI was used by 15 dermatologist evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. Results - Overall intra-evaluator reliability of the EASI was in the fair-to-good range. Inter-evaluator reliability analyses indicated that the evaluators assessed the patients consistently across both study days. Conclusions - This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 50 条
  • [1] Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis
    Chopra, R.
    Vakharia, P. P.
    Sacotte, R.
    Patel, N.
    Immaneni, S.
    White, T.
    Kantor, R.
    Hsu, D. Y.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : 1316 - 1321
  • [2] Remote severity assessment in atopic dermatitis: Validity and reliability of the remote Eczema Area and Severity Index and Self-Administered Eczema Area and Severity Index
    Ragamin, Aviel
    Schappin, Renske
    Nguyen, N. Tan
    Nouwen, Anouk E. M.
    Hoekstra, Lisanne F.
    Schuttelaar, Marie L. A.
    Pasmans, Suzanne G. M. A.
    JAAD INTERNATIONAL, 2023, 13 : 184 - 191
  • [3] REMOTE SEVERITY ASSESSMENT IN ATOPIC DERMATITIS: VALIDITY AND RELIABILITY OF THE REMOTE EASI AND SA-EASI
    Ragamin, Aviel
    Schappin, Renske
    Schuttelaar, Marie-Louise
    Nouwen, Anouk E. M.
    Hoekstra, Lisanne F.
    Nguyen, N. Tan
    Pasmans, Suzanne G. M. A.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 9 - 9
  • [4] Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores
    Wollenberg, Andreas
    Simon, Dagmar
    Kulthanan, Kanokvalai
    Figueras-Nart, Ignasi
    Misery, Laurent
    Tangsirisap, Nithi
    Spina, Lara
    Lu, Na
    Grond, Sussanne
    Eyerich, Kilian
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (04) : 695 - 702
  • [5] Relationship and probabilistic stratification of Eczema Area and Severity Index and objective Scoring Atopic Dermatitis severity scores for atopic dermatitis
    Hurault, G.
    Schram, M. E.
    Roekevisch, E.
    Spuls, P. I.
    Tanaka, R. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 1003 - 1005
  • [6] Validation of Remote AD Severity Assessment with the Eczema Area and Severity Index (EASI) Using Photos and Videos: Preliminary Reliability and Validity
    Croce, Emily
    Rathouz, Paul
    Silva, Fabiana Castro Porto
    Leszczynska, Maria
    Diaz, Lucia
    Levy, Moise
    Ruth, Jennifer
    Varshney, Pooja
    Matsui, Elizabeth
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB149 - AB149
  • [7] Model-based meta-analysis of topical treatments for atopic dermatitis: Eczema Area and Severity Index (EASI) as an efficacy endpoint
    Jen, Frank
    Ports, William C.
    Papacharalambous, Jocelyn
    Wang, Cunshan
    Ahadieh, Sima
    Purohit, Vivek S.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S32 - S33
  • [8] PRODUCT OF INVESTIGATOR GLOBAL ASSESSMENT AND BODY SURFACE AREA (IGAXBSA): A PRACTICE-FRIENDLY ALTERNATIVE TO ECZEMA ASSESSMENT AND SEVERITY INDEX/ EASI OR SCORING AD/SCORAD IN MEASURING PEDIATRIC ATOPIC DERMATITIS SEVERITY
    Suh, Timothy
    Ramachandran, Divya
    Patel, Vidhi
    Jackson, Kathryn
    Rangel, Stephanie M.
    Fishbein, Anna
    Paller, Amy
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 30 - 30
  • [9] Effectiveness of the Eczema Action Plan (EAP) in improving the Eczema Area and Severity Index (EASI) scores among pediatric patients with atopic dermatitis: A pragmatic randomized controlled trial
    Grace Sison, Maria Elinor
    Pauline Lazo-Dizon, Johanna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB118 - AB118
  • [10] Translating the Investigator's Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic Dermatitis
    Thyssen, Jacob P.
    Zang, Chuanbo
    Neary, Maureen P.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Cha, Amy
    Russo, Christopher
    Luger, Thomas A.
    DERMATOLOGY AND THERAPY, 2021, 11 (03) : 845 - 853